Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway
V. Wong(Burke Medical Research Institute), Gary F. Lewis(Toronto General Hospital)
Cited by 10
Related Papers
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
|European Heart Journal|2021|889